The average one-year price target for AGNC Investment - Preferred Stock (NASDAQGS:AGNCP) has been revised to $31.15 / share. This is an increase of 10.19% from the prior estimate of $28.27 dated September 13, 2026. The price target is an average of many targets
The average one-year price target for Gold Royalty - Equity Warrant (NYSEAM:GROY.WS) has been revised to $1.92 / share. This is a decrease of 10.68% from the prior estimate of $2.15 dated September 13, 2026. These figures represent an aggregate of analyst targets
The average one-year price target for Sono-Tek (NASDAQCM:SOTK) has been revised to $8.67 / share, up 13.33% from the prior estimate of $7.65 dated September 11, 2026. These figures represent aggregate analyst targets and do not constitute a recommendation by Fintel.Latest analyst
Key PointsMicrosoft's Copilot has 30 million paying subscribers, and the latest version of the productivity app offers even more AI-focused capabilities.
Fintel reports that on October 1, 2026, Morgan Stanley initiated coverage of Lennar (NYSE:LEN.B) (DB:LNN0) with a Underweight recommendation.Lennar Corporation, based in the United States, is a prominent player in the home construction industry. The company focuses on building af
Corn futures were fighting to stay above $5 for much of the session despite hitting a low of $4.95 in the December contract. Bulls battled back to close with contracts steady to 1 ½ cents higher. The CmdtyView national average Cash Corn price was up 3 1/4 cents at $4.61...
The average one-year price target for Adamas Trust, Inc. - Preferred Stock (NASDAQGS:ADAMM) has been revised to $32.16 / share. This is an increase of 14.83% from the prior estimate of $28.01 dated September 13, 2026. These figures represent aggregate analyst ta
The average one-year price target for IQM Quantum Computers Oyj - Depositary Receipt (NASDAQGS:IQMX) (DB:561) has been revised to $16.58 / share. This is an increase of 30.00% from the prior estimate of $12.75 dated September 11, 2026. These figures represent aggregate analyst ta
The average one-year price target for Teva Pharmaceutical Industries Limited - Depositary Receipt (NYSE:TEVA) has been revised to $0.13 / share, up 19.98% from the prior estimate of $0.11 dated September 13, 2026. These figures represent aggregate analyst targets compiled by Fint
(RTTNews) - Nanobiotix S.A. (NBTX), a late-stage clinical biotechnology company developing physics-based nano-therapeutics for cancer and other major diseases, announced the appointment of Arnd Christ as Chief Financial Officer (CFO) and a member of its executive board.
(RTTNews) - Addex Therapeutics Ltd. (ADXN), a clinical-stage biopharmaceutical company, on Friday announced the appointment of Jean-Phillippe Rocher as the Head of Pharmaceutical Development, and a member of the Executive Management.
The average one-year price target for TruGolf Holdings (NASDAQCM:TRUG) has been revised to $61.20 / share. This is an increase of 900.00% from the prior estimate of $6.12 dated September 11, 2026. These figures represent aggregate analyst targets compiled by Fintel and do not con
(RTTNews) - Daiichi Sankyo (4568.TS) and AstraZeneca (AZN) have entered into a clinical trial collaboration agreement with Summit Therapeutics (SMMT) to evaluate Datroway (datopotamab deruxtecan) in combination with ivonescimab across multiple solid tumor types, expanding efforts